Literature DB >> 10729166

Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions.

L Kolesnikova1, E Mühlberger, E Ryabchikova, S Becker.   

Abstract

HeLa cells expressing the recombinant Marburg virus (MBGV) nucleoprotein (NP) have been studied by immunoelectron microscopy. It was found that MBGV NPs assembled into large aggregates which were in close association with membranes of the rough endoplasmic reticulum. Further analysis of these aggregates revealed that NPs formed tubule-like structures which were arranged in a hexagonal pattern. A similar pattern of preformed nucleocapsids was detected in intracellular inclusions induced by MBGV infection. Our data indicated that MBGV NP is able to form nucleocapsid-like structures in the absence of the authentic viral genome and other nucleocapsid-associated proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729166      PMCID: PMC111900          DOI: 10.1128/jvi.74.8.3899-3904.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Interactions of Marburg virus nucleocapsid proteins.

Authors:  S Becker; C Rinne; U Hofsäss; H D Klenk; E Mühlberger
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

2.  Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes.

Authors:  E Mühlberger; B Lötfering; H D Klenk; S Becker
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

3.  Differentiation of filoviruses by electron microscopy.

Authors:  T W Geisbert; P B Jahrling
Journal:  Virus Res       Date:  1995-12       Impact factor: 3.303

4.  The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly.

Authors:  C J Buchholz; D Spehner; R Drillien; W J Neubert; H E Homann
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

5.  The nucleoprotein of Marburg virus is phosphorylated.

Authors:  S Becker; S Huppertz; H D Klenk; H Feldmann
Journal:  J Gen Virol       Date:  1994-04       Impact factor: 3.891

6.  Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy.

Authors:  T W Geisbert; N K Jaax
Journal:  Ultrastruct Pathol       Date:  1998 Jan-Feb       Impact factor: 1.094

7.  Respiratory Marburg virus infection in guinea pigs.

Authors:  E Ryabchikova; L Strelets; L Kolesnikova; O Pyankov; A Sergeev
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells.

Authors:  S Becker; H D Klenk; E Mühlberger
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

9.  Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.

Authors:  G Sutter; M Ohlmann; V Erfle
Journal:  FEBS Lett       Date:  1995-08-28       Impact factor: 4.124

10.  The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain.

Authors:  A A Bukreyev; V E Volchkov; V M Blinov; S A Dryga; S V Netesov
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more
  48 in total

1.  Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells.

Authors:  C Sänger; E Mühlberger; E Ryabchikova; L Kolesnikova; H D Klenk; S Becker
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment.

Authors:  Larissa Kolesnikova; Harald Bugany; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway.

Authors:  Larissa Kolesnikova; Sandra Bamberg; Beate Berghöfer; Stephan Becker
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

4.  Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread.

Authors:  Kristina Maria Schmidt; Michael Schümann; Judith Olejnik; Verena Krähling; Elke Mühlberger
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles.

Authors:  Olga Dolnik; Larissa Kolesnikova; Lea Stevermann; Stephan Becker
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

6.  Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.

Authors:  Jens H Kuhn; Stephan Becker; Hideki Ebihara; Thomas W Geisbert; Karl M Johnson; Yoshihiro Kawaoka; W Ian Lipkin; Ana I Negredo; Sergey V Netesov; Stuart T Nichol; Gustavo Palacios; Clarence J Peters; Antonio Tenorio; Viktor E Volchkov; Peter B Jahrling
Journal:  Arch Virol       Date:  2010-10-30       Impact factor: 2.574

7.  Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription.

Authors:  Peggy Möller; Nonia Pariente; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  VP24 of Marburg virus influences formation of infectious particles.

Authors:  Sandra Bamberg; Larissa Kolesnikova; Peggy Möller; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.